[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363042-105":59,"doc-detail-363042-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-ddx39a-in-modulating-the-tumor-progression-and-radiosensitivity-in-esophageal-squamous-cell-carcinoma","Role of DDX39A in modulating the tumor progression and radiosensitivity in esophageal squamous cell carcinoma","","Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy where radiotherapy is central, yet intrinsic and acquired radioresistance often drives locoregional recurrence and progression. This study investigates DDX39A, a DEAD-box RNA helicase, as a potential regulator of ESCC pathogenesis and therapeutic resistance. Bioinformatics and experimental approaches define DDX39A upregulation, malignant phenotypes, and enhanced radiosensitivity after knockdown, linking the mechanism to an SP1–Ku70 axis that promotes non-homologous end joining–mediated radioresistance. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-ddx39a-in-modulating-the-tumor-progression-and-radiosensitivity-in-esophageal-squamous-cell-carcinoma/363042/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-ddx39a-in-modulating-the-tumor-progression-and-radiosensitivity-in-esophageal-squamous-cell-carcinoma/363042.png","ImageObject",300,407,{"name":92,"@type":93},"Chumphorn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the paper address in ESCC treatment?","Question",{"text":112,"@type":113},"The paper addresses radioresistance in esophageal squamous cell carcinoma, which limits the effectiveness of radiotherapy and leads to locoregional recurrence and disease progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the role of DDX39A studied in ESCC?",{"text":117,"@type":113},"The study used bioinformatics analyses, immunohistochemistry, functional assays, proteomics, and mechanistic experiments including RIP-qPCR, ChIP-qPCR, dual-luciferase reporter assays, and in vivo murine xenograft validation.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links DDX39A to radioresistance?",{"text":121,"@type":113},"DDX39A binds to SP1 mRNA, stabilizing it and enhancing SP1 translation. Increased SP1 protein activates Ku70 transcription in the non-homologous end joining pathway, and rescue experiments support that the DDX39A–SP1–Ku70 axis is necessary and sufficient for radioresistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363042,1790269521,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Cellular Oncology (2026) 49:73  \n[https://doi.org/10.1007/s13402-026-01206-5](https://doi.org/10.1007/s13402-026-01206-5)  \nRESEARCH  \nRole of DDX39A in modulating the tumor progression and radiosensitivity in esophageal squamous cell carcinoma  \nBeina Hui1 · Weibin Hu1 · Xin Chen2 · Ying Wang1 · Jing Li1 · Yuchen Sun1 · Xuanzi Sun1 · Juan Ren1  \nReceived: 7 May 2025 / Accepted: 1 April 2026 © The Author(s) 2026  \nAbstract  \nPurpose Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with limited treatment options. Although radiotherapy remains a cornerstone of curative treatment, intrinsic and acquired radioresistance frequently lead to locoregional recurrence and disease progression. DDX39A, a DEAD-box RNA helicase, regulates RNA metabolism in diverse cellular contexts; however, its role in ESCC pathogenesis and therapeutic resistance remains unclear.  \nMethods Bioinformatics analyses, immunohistochemistry, and functional assays were performed to characterize the role of DDX39A in ESCC. Tandem mass tag-based proteomics was used to identify downstream effectors. Mechanistic studies included RIP-qPCR, ChIP-qPCR, and dual-luciferase reporter assays. The therapeutic relevance was further validated using murine xenograft models.  \nResults DDX39A was significantly upregulated in ESCC tissues and cell lines, and its high expression correlating with increased tumor proliferation. DDX39A knockdown suppressed malignant phenotypes and markedly enhanced radiosensitivity. Mechanistically, SP1 was prioritized from proteomic screening owing to its central role as a transcription factor regulating DNA repair gene expression. DDX39A directly binds to SP1 mRNA, stabilizing it and enhancing its translation efficiency without affecting transcription. The resulting increase in SP1 protein promotes binding to the − 223/−214 bp region of the Ku70 promoter, thereby transcriptionally activating this key component of the non-homologous end joining pathway and contributing to radioresistance. Rescue experiments confirmed that the DDX39A–SP1–Ku70 axis is both necessary and sufficient to mediate radioresistance. In vivo, DDX39A silencing enhanced radiosensitivity and improved tumor control in ESCC models.  \nConclusions These findings identify DDX39A as a promising therapeutic target in ESCC radioresistance. The DDX39A– SP1–Ku70 axis provides a mechanistic rationale for the development of novel radiosensitization strategies.  \nKeywords Esophageal squamous cell carcinoma · Resistance to radiation · DDX39A · SP1 · Ku70  \nAbbreviations  \nESCC Esophageal squamous cell carcinoma  \nXRCC6 X-Ray repair cross-complementing protein 6  \nEMT Epithelial–mesenchymal transition  \nTCGA The Cancer Genome Atlas  \nGEO Gene Expression Omnibus  \n􀀍 Juan Ren [869491533@qq.com](869491533@qq.com)  \n1 Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, No.277 Yanta West Road, Xi’an, Shaanxi 710061, China  \n2 Department of Radiation Oncology, Shaanxi Provincial People’s Hospital, Xi’an 710068, China  \nIHCqRT-PCRTMT  \nRIP  \nNHEJ  \nCHX  \nDSBs  \nImmunohistochemistry Real-time quantitative PCR Tandem mass tag  \nRNA immunoprecipitation Non-homologous end joining Cycloheximide  \nDNA double-strand breaks  \n1 Background  \nEsophageal cancer is the seventh most common malignancy worldwide and the sixth leading cause of cancer-related deaths [1] . The two major histological subtypes—squamous cell carcinoma (SCC) and adenocarcinoma—differ in  \n1 3  \nepidemiology and biology. SCC accounts for approximately 70% of cases globally and constitutes more than 90% of the disease burden in the so-called “Asian esophageal cancer belt,” including northern China, Central Asia, and Southeast Asia [2, 3] . The absence of early, specific symptoms and validated screening biomarkers results in most patients presenting with locally advanced or metastatic disease [4] . Definitive or adjuvant radiotherapy (RT) is central to curative-intent treatment; ho","cbCaisXl0OqiKdes","https://ap.wps.com/l/cbCaisXl0OqiKdes","pdf",4368921,16,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# Background\n## Esophageal cancer and radioresistance\n## DEAD-box RNA helicases and oncogenic roles\n## Rationale for targeting DDX39A","[{\"question\":\"What problem does the paper address in ESCC treatment?\",\"answer\":\"The paper addresses radioresistance in esophageal squamous cell carcinoma, which limits the effectiveness of radiotherapy and leads to locoregional recurrence and disease progression.\"},{\"question\":\"How was the role of DDX39A studied in ESCC?\",\"answer\":\"The study used bioinformatics analyses, immunohistochemistry, functional assays, proteomics, and mechanistic experiments including RIP-qPCR, ChIP-qPCR, dual-luciferase reporter assays, and in vivo murine xenograft validation.\"},{\"question\":\"What mechanism links DDX39A to radioresistance?\",\"answer\":\"DDX39A binds to SP1 mRNA, stabilizing it and enhancing SP1 translation. Increased SP1 protein activates Ku70 transcription in the non-homologous end joining pathway, and rescue experiments support that the DDX39A–SP1–Ku70 axis is necessary and sufficient for radioresistance.\"}]","Role of DDX39A in modulating the tumor progression and radiosensitivity in esophageal squamous cell carcinoma | PDF",1790149757,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bc11938d8d10582580d83f2b721f98e.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a781209a659ba8682423a863f1d7359.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51fe68491420da8a1609fa2ba1695792.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4af6139377325bd2edab710bbdd583aa.webp",980,1301]